Dr Daniel G Balcueva, OD in Troy, MI - Medicare Optometry Provider

Dr Daniel G Balcueva, OD is a medicare enrolled "Optometrist" provider in Troy, Michigan. He went to Indiana University - School Of Optometry and graduated in 2012 and has 12 years of diverse experience with area of expertise as Optometry. He is a member of the group practice P-cor Llc and his current practice location is 735 John R Rd, Troy, Michigan. You can reach out to his office (for appointments etc.) via phone at (248) 544-3290.

Dr Daniel G Balcueva is licensed to practice in Michigan (license number 4901004830) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1659636017.

Contact Information

	Dr Daniel G Balcueva, OD
	735 John R Rd, Troy, MI 48083-5856
	(248) 544-3290
	(248) 528-4040

Healthcare Provider's Profile

Full Name	Dr Daniel G Balcueva
Gender	Male
Speciality	Optometry
Experience	12 Years
Location	735 John R Rd, Troy, Michigan
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Daniel G Balcueva attended and graduated from Indiana University - School Of Optometry in 2012

NPI Data:

NPI Number: 1659636017
Provider Enumeration Date: 07/11/2012
Last Update Date: 09/15/2015

Medicare PECOS Information:

PECOS PAC ID: 3173776382
Enrollment ID: I20141106000208

Medical Identifiers

Medical identifiers for Dr Daniel G Balcueva such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1659636017	NPI	-	NPPES
201202570	Medicaid	IN
1659636017	Medicaid	MI

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
152W00000X	Optometrist	18003721 (Indiana)	Secondary
152W00000X	Optometrist	4901004830 (Michigan)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
P-cor Llc	9931194149	77

News Archive

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Factors such as increased risk for African-Americans, obesity and medical distrust contribute to high rates of prostate cancer in Louisiana. Louisiana has the fourth highest prostate cancer death rate in the country and the sixth highest incidence rate, according to data from North American Association of Central Cancer Registries, National Cancer Institute and the Centers for Disease Control and Prevention.

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

New developments such as stereotactic ablative radiotherapy and improvements in surgical care in early-stage lung cancer have led to large survival gains for elderly Dutch patients, according to a population-based study presented at the 14th World Conference on Lung Cancer in Amsterdam, hosted by the International Association for the Study of Lung Cancer.

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company focused on the hospital acute care and gastroenterology markets, today announced second quarter 2009 financial results.

Next-generation DNA sequencing demonstrates potential in identifying mutations in SCLC

Applied Biosystems, part of Life Technologies Corporation, today announced the publication of a paper in the journal Nature that demonstrates the power of next-generation DNA sequencing used to identify DNA mutations in a small cell lung cancer (SCLC) line and identify the mutational burden associated with tobacco smoking.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Daniel G Balcueva allows following entities to bill medicare on his behalf.

Provider Name	P-cor Llc
Provider Type	Part B Supplier - Clinic/group Practice
Provider Identifiers	NPI Number: 1720033343 PECOS PAC ID: 9931194149 Enrollment ID: O20040417000048

News Archive

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Next-generation DNA sequencing demonstrates potential in identifying mutations in SCLC

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Daniel G Balcueva is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Daniel G Balcueva, OD 655 W 13 Mile Rd, Madison Heights, MI 48071-1850 Ph: (248) 588-9300	Dr Daniel G Balcueva, OD 735 John R Rd, Troy, MI 48083-5856 Ph: (248) 544-3290

News Archive

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Next-generation DNA sequencing demonstrates potential in identifying mutations in SCLC

Optometrist in Troy, MI

Sandra Shina Hou, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2001 W Maple Rd, Wal Mart Vision Center, Troy, MI 48084 Phone: 248-435-4126 Fax: 248-435-4162
Svs Vision Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6828 Rochester Rd, Troy, MI 48085 Phone: 248-710-1100 Fax: 248-786-2928
Andrea M. Langolf, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2877 Crooks Rd, Ste B, Troy, MI 48084 Phone: 248-822-7003 Fax: 248-822-7008
Sasha Shammami Kashat, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1301 Coolidge Hwy, Troy, MI 48084 Phone: 248-643-9880
Dr. Rhonda Elisha Thompson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd, Troy, MI 48083 Phone: 248-951-0000 Fax: 248-528-4040
Dr. Bruce Richard Wolffis, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 735 John R Rd Ste 150, Troy, MI 48083 Phone: 248-577-3659 Fax: 248-588-9917
Dr. Timothy Schrot, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 506 W 14 Mile Rd, Troy, MI 48083 Phone: 248-589-8240 Fax: 248-589-2597

Dr Daniel G Balcueva, OD - Medicare Optometrist in Troy, MI

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Next-generation DNA sequencing demonstrates potential in identifying mutations in SCLC

Medicare Reassignments

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Next-generation DNA sequencing demonstrates potential in identifying mutations in SCLC

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Obesity, medical distrust contribute to high rates of prostate cancer in Louisiana

Stereotactic ablative radiotherapy improves median survival for elderly Dutch NSCLC patients

Cumberland Pharmaceuticals posts $9.8 million revenues for the three months ended June 30, 2009

Next-generation DNA sequencing demonstrates potential in identifying mutations in SCLC

Optometrist in Troy, MI